Finally, we found that the pharmacological inhibition of ERAP1 affected SHH-MB Patient-Derived Xenograft (PDX)63 cell proliferation and increased tumor cell death in a dose- and time-dependent manner leading to apoptosis, as indicated by increased cleaved Caspase-3 positive cells (Fig. 7a–e). Here, ERAP1 is linked to neoplasm.